0001209191-19-060018.txt : 20191211 0001209191-19-060018.hdr.sgml : 20191211 20191211161012 ACCESSION NUMBER: 0001209191-19-060018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191209 FILED AS OF DATE: 20191211 DATE AS OF CHANGE: 20191211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Flynn Daniel Lee CENTRAL INDEX KEY: 0001713712 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38219 FILM NUMBER: 191279903 MAIL ADDRESS: STREET 1: C/O DECIPHERA PHARMACEUTICALS, LLC STREET 2: 500 TOTTEN POND ROAD CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001654151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200299725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 SMITH STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-209-6400 MAIL ADDRESS: STREET 1: 200 SMITH STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC DATE OF NAME CHANGE: 20150928 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-09 0 0001654151 Deciphera Pharmaceuticals, Inc. DCPH 0001713712 Flynn Daniel Lee C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STREET WALTHAM MA 02451 0 1 0 0 Chief Scientific Officer Common Stock 2019-12-09 4 M 0 30175 1.89 A 54675 D Common Stock 2019-12-09 4 S 0 30175 55.00 D 24500 D Common Stock 2019-12-10 4 M 0 28822 1.89 A 53322 D Common Stock 2019-12-10 4 S 0 28822 55.00 D 24500 D Common Stock 2019-12-10 4 M 0 93930 1.89 A 118430 D Common Stock 2019-12-10 4 S 0 93930 55.00 D 24500 D Common Stock 66779 I By Daniel L. Flynn Irrevocable Trust Common Stock 55270 I By Biochenomix, LLC Stock Option (Right to Buy) 1.89 2019-12-09 4 M 0 30175 0.00 D 2025-12-17 Common Stock 30175 136649 D Stock Option (Right to Buy) 1.89 2019-12-10 4 M 0 28822 0.00 D 2025-12-17 Common Stock 28822 107827 D Stock Option (Right to Buy) 1.89 2019-12-10 4 M 0 93930 0.00 D 2025-12-17 Common Stock 93930 13897 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015. /s/ Thomas P. Kelly, Attorney-in-Fact 2019-12-11